Total Current Liabilities
Bristol-Myers Squibb Total Current Liabilities decreased by 18.2% to $19.16B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.4%, from $24.07B to $19.16B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows an upward trend with a 4.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
High levels relative to current assets may indicate liquidity stress, while low levels suggest strong short-term financial health.
Detailed definition
This is the sum of all financial obligations due within one year, including accounts payable, short-term debt, and accru...
Peer comparison
Pharmaceutical firms typically maintain a balanced current ratio, keeping current liabilities in line with operational cash flow.
total_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.99B | $21.46B | $21.87B | $22.82B | $20.92B | $18.93B | $21.89B | $19.09B | $20.15B | $23.46B | $22.26B | $25.82B | $23.27B | $22.64B | $23.77B | $24.07B | $27.53B | $28.14B | $23.42B | $19.16B |
| QoQ Change | — | +13.0% | +1.9% | +4.4% | -8.4% | -9.5% | +15.6% | -12.8% | +5.6% | +16.4% | -5.1% | +16.0% | -9.9% | -2.7% | +5.0% | +1.2% | +14.4% | +2.2% | -16.8% | -18.2% |
| YoY Change | — | — | — | — | +10.1% | -11.8% | +0.1% | -16.4% | -3.7% | +23.9% | +1.7% | +35.3% | +15.5% | -3.5% | +6.8% | -6.8% | +18.3% | +24.3% | -1.5% | -20.4% |
Total Current Liabilities at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total current liabilities?
- Bristol-Myers Squibb (BMY) reported total current liabilities of $19.16B in Q1 2026.
- How has Bristol-Myers Squibb's total current liabilities changed year-over-year?
- Bristol-Myers Squibb's total current liabilities decreased by 20.4% year-over-year, from $24.07B to $19.16B.
- What is the long-term trend for Bristol-Myers Squibb's total current liabilities?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total current liabilities has grown at a 4.2% compound annual growth rate (CAGR), from $19.08B to $23.42B.
- What does total current liabilities mean?
- The total amount of all debts and obligations the company must pay within one year.